Filters: Tags: Aquaculture (X)678 results (197ms)
A review of pond zooplankton production and fertilization for the culture of larval and fingerling striped bass
Demonstrating ecological engineering for wastewater treatment in a Nordic climate using aquaculture principles in a greenhouse mesocosm
Simultaneous production of beta -carotene, vitamin E and vitamin C by the aerial microalga Trentepohlia aurea
Chloramine-T is presently available in the USA to control mortalities associated with bacterial gill disease or external columnaris only through an Investigational New Animal Drug Permit authorized by the US Food and Drug Administration (FDA). Its US approval hinges on FDA's acceptance of several key data, including those describing animal safety. Chloramine-T is presently applied in US aquaculture, by permit only, once daily on consecutive or alternate days for 1??h at 10 to 20??mg/L to control mortalities associated with bacterial gill disease or external columnaris. Our objective was to determine the safety of chloramine-T bath exposures at multiples of the proposed maximum treatment concentration (i.e., 0, 20,...
Depletion of isoeugenol residues from the fillet tissue of AQUI-S™ exposed rainbow trout (<i>Oncorhynchus mykiss</i>)
There is a critical need in U.S. public aquaculture and fishery management for an approved sedative that allows for the immediate release of fish after sedation. AQUI-STM is a fish anesthetic/sedative approved for use in several countries and until recently was being developed in the U.S. as a sedative for immediate release of fish after sedation. The U.S. National Toxicology Program reported that isoeugenol (the active ingredient in AQUI-STM) exposed male mice showed clear evidence of carcinogenicity, therefore efforts within the U.S. Department of Interior to develop AQUI-STM as a sedative that allows for immediate release ceased. Despite the ruling, AQUI-STM still has the potential to be approved as an anesthetic...